Please login to the form below

Not currently logged in
Email:
Password:

Takeda appoints head of vaccines development

John Boslego will succeed Ralf Clemens

edit-Boslego-photo-2Takeda Pharmaceuticals has appointed John Boslego as senior vice president and head of development for its global vaccine business unit, effective from December 1.

He succeeds Ralf Clemens, who has served in the role since the launch of Takeda's vaccine business division in January 2012.

Boslego will be responsible for accelerating global vaccine development activities with a focus on lead development programmes for dengue, norovirus and seasonal influenza. He will report to Rajeev Venkayya, president of Takeda's global vaccine business unit.

Commenting on the appointment, Venkayya said: “John brings a wealth of vaccine development and global health experience to Takeda at an important time.

“He takes the helm of an outstanding development team that was built by Ralf Clemens and I have the utmost confidence in their ability to deliver our exciting pipeline.”

Boslego has work in vaccine clinical research and development for over 40 years and was most recently director of the vaccine development global programme at PATH, where he built a vaccine development organisation and advanced vaccine development against illnesses including rotavirus, polio and meningococcus.

He has also served as executive director of biologics, clinical research at Merck & Co and prior to this, directed the Armed Forces Research Institute of Medical Sciences (AFRIMS) in Bangkok, Thailand.

14th October 2014

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Digitas Health

Digitas Health is the only digital-at-the-core brand agency designed to connect today's healthcare brands with today's healthcare consumers and professionals....

Latest intelligence

NHS regional footprints
What to expect from 2019...
Not another weight-loss ad
Christmas is over and the gyms are packed, it’s a never-ending tale. But why do we do it to ourselves every year?...
China’s clinical trial shake-up
As many of the obstacles to running clinical trials in China fall away, the country is proving to be a better research location...

Infographics